Casdin Eli
SEC CIK 1534264 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | Dir, 10% | 24.1K | $80.02M | $60.45M | 13 | 2021-07-22 | 2026-06-18 |
| LAB | STANDARD BIOTOOLS INC. | Dir, 10% | 3.05M | $10.48M | — | 17 | 2022-04-04 | 2026-06-18 |
| BLFS | BIOLIFE SOLUTIONS INC | 10% | 7.21M | $10.37M | $35.10M | 4 | 2021-09-01 | 2025-08-11 |
| TNYA | Tenaya Therapeutics, Inc. | Dir, 10% | 3.22M | $12.75M | — | 2 | 2021-08-03 | 2021-08-03 |
| MXCT | MAXCYTE, INC. | 10% | 13.97M | $23.40M | — | 1 | 2021-07-30 | 2021-07-30 |
| ABSI | Absci Corp | Dir | 4.21M | $25.00M | — | 2 | 2021-07-26 | 2021-07-26 |
Most active insiders at WGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir, 10% | $74.03M | — |
| 2 | Casdin Capital, LLC | Dir, 10% | $32.57M | — |
| 3 | Stueland Katherine | CEO, Dir | — | $12.90M |
| 4 | RUCH JOSHUA | Dir | — | $6.09M |
| 5 | Feeley Kevin | CFO | — | $4.07M |
| 6 | Dechairo Bryan | COO | — | $850.6K |
| 7 | Fuchs Thomas | Dir | — | — |
| 8 | Leproust Emily M. | Dir | — | — |
| 9 | Ryan Jason | Dir | — | — |
| 10 | Casdin Eli | Dir, 10% | — | — |
Transactions 39
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:41 | 2026-06-18 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +99.1K | 3.05M | +3% | $0 |
| D | 2026-06-23 16:25 | 2026-06-18 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | M - OptEx | $0.00 | +3,576 | 24.1K | +17% | $0 |
| 2026-03-02 | 2026-02-26 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $1.17 | +53.0K | 2.95M | +2% | +$62.0K | |
| MI | 2025-11-20 | 2025-11-18+ | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | P - Purchase | $1.28 | +1.07M | 63.60M | +2% | +$1.37M |
| MI | 2025-09-05 | 2025-09-03+ | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | P - Purchase | $1.27 | +500.0K | 60.52M | +0.8% | +$637.5K |
| I | 2025-08-22 | 2025-08-22 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | S - Sale | $120.90 | -500.0K | 3.01M | -14% | -$60.45M |
| MI | 2025-08-15 | 2025-08-13+ | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | P - Purchase | $1.24 | +358.2K | 59.75M | +0.6% | +$442.4K |
| I | 2025-08-13 | 2025-08-11 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Eli | 10% | S - Sale | $22.60 | -500.0K | 7.21M | -6% | -$11.30M |
| DA | 2025-08-07 | 2025-06-18 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | M - OptEx | $0.00 | +12.9K | 20.5K | +170% | $0 |
| D | 2025-06-24 | 2025-06-20 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +94.6K | 2.90M | +3% | $0 |
| D | 2025-06-23 | 2025-06-18 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | M - OptEx | $0.00 | +12.9K | 20.5K | +170% | $0 |
| I | 2025-06-12 | 2025-06-10 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Eli | 10% | S - Sale | $23.80 | -1.00M | 7.71M | -11% | -$23.80M |
| MI | 2024-08-06 | 2024-08-02+ | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | P - Purchase | $1.62 | +1.20M | 47.73M | +3% | +$1.95M |
| 2024-07-23 | 2024-07-19 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +1,588 | 2.75M | +0.1% | $0 | |
| D | 2024-07-02 | 2024-06-28 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +43.1K | 2.75M | +2% | $0 |
| D | 2024-06-24 | 2024-06-20 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | M - OptEx | $0.00 | +5,828 | 7,593 | +330% | $0 |
| 2024-05-31 | 2024-05-29 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | P - Purchase | $21.07 | +40.0K | 2.96M | +1% | +$842.8K | |
| M | 2024-05-28 | 2024-05-23+ | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | P - Purchase | $20.15 | +170.0K | 2.92M | +6% | +$3.43M |
| MI | 2024-05-17 | 2024-05-15+ | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | P - Purchase | $2.56 | +1.35M | 45.38M | +3% | +$3.46M |
| 2024-02-22 | 2024-02-20 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $2.50 | +22.8K | 103.6K | +28% | +$57.0K | |
| DMI | 2024-01-09 | 2024-01-05 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | — | +21.54M | 7.55M | New | — |
| DM | 2024-01-09 | 2024-01-05 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | — | +7,614 | 80.8K | +10% | — |
| 2023-10-23 | 2023-10-19 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Eli | 10% | P - Purchase | $11.19 | +927.2K | 8.56M | +12% | +$10.37M | |
| D | 2023-06-16 | 2023-06-14 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir | A - Grant | $0.00 | +26.4K | 73.1K | +56% | $0 |
| MI | 2023-05-19 | 2023-05-17+ | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | P - Purchase | $2.19 | +1.20M | 1.20M | New | +$2.63M |
| D | 2023-05-04 | 2023-05-02 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir | M - OptEx | $0.00 | +45.5K | 58.3K | +354% | $0 |
| MI | 2023-02-02 | 2023-01-31 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir, 10% | P - Purchase | $0.35 | +85.71M | 87.87M | +3,983% | +$30.00M |
| D | 2022-06-17 | 2022-06-15 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir | A - Grant | $0.00 | +30.9K | 46.8K | +195% | $0 |
| D | 2022-05-12 | 2022-04-27 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir | M - OptEx | — | +12.8K | 12.8K | New | — |
| I | 2022-05-03 | 2022-04-29 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir | P - Purchase | $4.00 | +11.44M | 16.44M | +229% | +$45.75M |
| D | 2022-04-06 | 2022-04-04 | LAB | STANDARD BIOTOOLS INC. | Casdin Eli | Dir, 10% | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
| 2021-11-03 | 2021-09-01 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Eli | 10% | J - Other | — | +126.2K | 7.57M | +2% | — | |
| DI | 2021-08-04 | 2021-08-03 | TNYA | Tenaya Therapeutics, Inc. | Casdin Eli | Dir, 10% | P - Purchase | $15.00 | +850.0K | 3.22M | +36% | +$12.75M |
| DMI | 2021-08-04 | 2021-08-03 | TNYA | Tenaya Therapeutics, Inc. | Casdin Eli | Dir, 10% | C - Cnv Deriv | $0.00 | +2.74M | 2.37M | New | $0 |
| 2021-08-03 | 2021-07-30 | MXCT | MAXCYTE, INC. | Casdin Eli | 10% | P - Purchase | $13.00 | +1.80M | 13.97M | +15% | +$23.40M | |
| DMI | 2021-07-28 | 2021-07-26 | ABSI | Absci Corp | Casdin Eli | Dir | C - Cnv Deriv | — | +6.16M | 4.21M | New | — |
| DI | 2021-07-28 | 2021-07-26 | ABSI | Absci Corp | Casdin Eli | Dir | P - Purchase | $16.00 | +1.56M | 6.75M | +30% | +$25.00M |
| DI | 2021-07-27 | 2021-07-22 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir | C - Cnv Deriv | $0.00 | +10.99M | 10.99M | New | $0 |
| DI | 2021-07-27 | 2021-07-22 | WGS | GeneDx Holdings Corp. | Casdin Eli | Dir | A - Grant | $0.00 | +5.00M | 5.00M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations